Pharmacy Podcast Network

Novel Non-stimulant ADHD Treatments: A Review for Pharmacists | PTCE Pharmacy Connect

Educational Objectives
Describe the impact of ADHD and new non-stimulant class of ADHD treatments
Highlight the role of the pharmacist in patient counseling, monitoring and medication management in ADHD
Faculty:
Sandy Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Child and Adolescent Psychiatry 
Department of Pharmacy 
Virginia Commonwealth University (VCU) Health
Richmond, VA
Sandy Mullen, PharmD, BCPP, has no financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-22-127-H01-P. The activity is available for CE credit through March 30, 2023.
This activity is supported by an educational grant from Supernus.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Digital Health with Bakul Patel | Darshan Talks

In this episode of the DarshanTalks Podcast, we have a discussion about Digital Health with Bakul Patel, Director, Digital Health Center of Excellence of US FDA department. He has over 28 years of leadership, business development, marketing, product management, assessing long and short-term needs, establishing objectives, improving organizational performance, and resource management. Expertise in medical device regulations, product development processes, software engineering, embedded systems, wireless communication systems, and robotics and control systems. Masters in Electronics Engineering, MBA in International Business. Six Sigma, Black-belt certified. With all the bucket of knowledge of digital health, the conversation started off with FDA going through massive changes currently. He explains his area of work in the digital health technology sphere and leading digital health with no jurisdiction boundaries, as this sector is wide in nature, and he further explains how it's always been fun to work in such an atmosphere. When it comes down to FDA there are portions of that spectrum of digital health as it may be general wellness. According to the expert, digital health is a spectrum, a continuum, a journey for an individual and purview under FDA's jurisdiction. The focus of the conversation was on the department that the expert works and the people who don't know much about can reach out to the department for advice, suggestions, reviews or portions of review depending on the products that come to different parts of the agency. There are some policy challenges, he emphasised on FDA needs to start evolving that their agency have been actively working on with other parts of the agency. Recent guidance on digital health tech in clinical trials was launched by his department and he described all the related information and implications in this podcast.
----
Disclaimers:
1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact.
2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization.
3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product.
4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice.
5. This does not create an attorney-client relationship.
Learn more about your ad choices. Visit megaphone.fm/adchoices

An Insider Discusses How Government Affairs Work Affects Your Pharmacy | Pharmacy Crossroads

If you have ever wondered what government affairs executives do and how they affect the practice of pharmacy then you’ll want to spend 35 minutes listening to this episode. Mark Kinney, a pharmacist, has more spent more than 30 years meeting with elected officials and other influential officials to help them better understand the complex and important role pharmacy owners play in our society. And, as you’ll learn in this podcast, government affairs work goes far beyond PBM and DIR fee battles.  
 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Clinical Decision Support Software: A Key Tool for Optimizing Population Health Level Pharmacogenomics Programs | PGx For Pharmacist

Episode Description:
On this episode, Dr. Jeffrey Shaman, Chief Science Officer at Coriell Life Sciences, and I discuss the importance of population health level pharmacogenomics versus one time pharmacogenomics tests and how clinical decision support software that integrates pharmacogenomics data into patients’ medication therapy management is a key tool to optimize population health level pharmacogenomics programs.
References:
1. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program https://www.mdpi.com/2075-4426/12/3/421
2. Idiopathic Symptoms Resolved by Pharmacogenomics-Enriched Comprehensive Medication Management: A Case Report https://www.cureus.com/articles/81096-idiopathic-symptoms-resolved-by-pharmacogenomics-enriched-comprehensive-medication-management-a-case-report
3. Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry https://www.coriell.com/resources/consequences-of-cyp2d6-copy-number-variation-for-pharmacogenomics-in-psychiatry/
4. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978656/
5. ASP Establishes March 24th as National Adverse Drug Event Awareness Day https://www.stopadr.org/blog/asp-establishes-march-24-as-national-adverse-drug-event-awareness-day-launches-awareness-campaign
Guest’s Bio:
Jeffrey A. Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences (CLS), an international leader in precision medicine. Leveraging extensive experience in genetics and pharmacology, he is a leading expert in the rapidly evolving field of pharmacogenomics (PGx), the study of how an individual’s DNA impacts his or her response to medication. Most importantly, Dr. Shaman plays a critical role in bridging the gap between genetic science and clinical application. This includes translating decades of cutting-edge genetic research into actionable insights on the safest and most effective medications for individuals based on their unique DNA and dozens of other factors.
Driven to advance public health, Dr. Shaman is focused on enabling the delivery of personalized medicine at scale and empowering the most precise medical care worldwide. He consults with large employers, public and private payer organizations, healthcare systems, academic institutions, and laboratories around the globe, advising them on how to eliminate trial-and-error prescribing, improve population health, and control rising healthcare costs
Dr. Shaman is dedicated to setting the industry standard for PGx and pioneering new advancements in the field. Along with his team, he actively researches and presents findings in top peer-reviewed journals and at leading industry events. He is an active member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, Personalized Medicine Coalition (PMC), Pharmacogenomics Global Research Network (PGRN), and other organizations.
Dr. Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell & Developmental Biology. Dr. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.
Learn more about your ad choices. Visit megaphone.fm/adchoices

DIRs, Clawbacks, & Opacity: CMS’ Drug Pricing Debacle | The PUTTcast

The unethical business practices by PBMs when it comes to our nation's seniors run the gamut from unreasonable fees and metrics to underhanded pricing models and what could easily be considered larceny against taxpayers. Join PUTTcast co-hosts Monique Whitney and Lauren Young, with special guests Tim Hamrick and Greg Reybold of APCI to discuss the results of their explosive 3Axis study, possible outcomes of the proposed CMS rule change, and why moving prescription drug plans to a NADAC pricing model is so important for lowering costs and increasing transparency.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Therapeutic Alternatives, Reimbursements, and the Economic Impact of ActiveRADAR | PBM Reform Podcast Series

Dave Teckman, Executive Chairman at ActiveRADAR joins the PBM Reform Podcast series about the impact of therapeutic interchange technologies on PBM pricing & the powerful data at the pharmacist's fingertips with ActiveRADAR.
Through rigorous clinical evaluation of all drugs in over 112 therapeutic categories, ActiveRADAR first establishes which drugs are clinically equivalent and therefore therapeutic alternatives to one another. This creates our Clinical Catalog of over 26,000+ therapeutically equivalent “perfect pairs”. Then ActiveRADAR determines the economic value using plan specific data to value each drug within its respective therapeutic class and sets pricing and reimbursement accordingly. This type of program has historically been called “reference pricing”, however ActiveRADAR takes it a step further by establishing both THE CLINICAL AND ECONOMIC VALUE OF EACH AND EVERY DRUG IN EACH THERAPEUTIC DRUG CLASS.
About ActiveRadar:
ActiveRADAR, formerly RxTE Health, is a healthcare analytics and patient education company providing unique data-driven, cost-saving customized prescription options. Using proprietary technology, ActiveRADAR identifies the lowest cost prescription options.
Learn more about your ad choices. Visit megaphone.fm/adchoices

PDS Super Conference 2022 Post-Show | Part TWO

PDS is 100% focused on equipping independent pharmacy owners with the skills they need to make their life better and their business more valuable. Each year, PDS hosts the leading independent pharmacy business conference, The PDS Super-Conference has thousands of pharmacy owners attend to discover what’s hot and what’s working right now in the industry. The Pharmacy Podcast Network was a proud media partner of the PDS 2022 Event.
Special Guests:
Jennifer Diehl, CPA, CPC, DBA
PDS | Business Coach
Drew Hegi, MBA
Loan Officer Pharmacy Owner dhegi@ffb1.com
Jon Allman and Mike Wilhoit
Mac's Pharmacy | Hometown Pharmacies in Tennessee
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Least of Us in Dreamland | PAIN POD

What do Mexico, drugs, society, the Bible, and whiskey have in common? Join us on this episode of the PAIN POD, as Mark “Pain Guy” Garofoli chats with Sam Quinones, author of “Dreamland” and “The Least of Us”, with the later having just released in October 2021. It’s often hard to see the forest within the trees, but Sam clears the fog for all of us to whittle it down on how to provide patient care for those in pain and/or with addiction. Come one, come all, to the Pain Pod!!!
Sam Quinones
https://samquinones.com/
Drug/Overdose Trends
https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates
https://www.iqvia.com/insights/the-iqvia-institute/reports/prescription-opioid-trends-in-the-united-states
FreeCE Substances of Abuse Specialty Pharmacist (SASP) Certificate
https://www.freece.com/Programs/SeriesCertification/ab66a419-b5e5-458b-9494-0acb6af1be92
CDC Opioid Guideline Updated Draft for Public Comment
https://www.regulations.gov/docket/CDC-2022-0024/document
Learn more about your ad choices. Visit megaphone.fm/adchoices

What Will Cost Plus Drugs mean for Your Pharmacy Long Term? | RMS CLIMB

What will Cost Plus Drugs mean for your pharmacy? What New Challenges does it bring and what opportunities does it present? And then what do you do about it? Join us for a discussion on the impact of of Cost Plus Drugs on retail pharmacy with Hartig Drug CEO Charlie Hartig.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Reverse Your Reliance on 503Bs for Compounded Sterile Products | The Future of Pharmacy Podcast

Learn how the University of Maryland Medical Center reversed its reliance on 503B vendors through an IV robotics insourcing program for compounded sterile products (CSPs). The result is a strategic services operation delivering advanced CSP services across its organization, resulting in improved safety, increased efficiencies, and significant cost savings
Learn more about your ad choices. Visit megaphone.fm/adchoices

PDS Super Conference 2022 Post-Show | Part ONE

PDS is 100% focused on equipping independent pharmacy owners with the skills they need to make their life better and their business more valuable. Each year, PDS hosts the leading independent pharmacy business conference, The PDS Super-Conference has thousands of pharmacy owners attend to discover what’s hot and what’s working right now in the industry. The Pharmacy Podcast Network was a proud media partner of the PDS 2022 Event.
In this episode:
Marci Strauss PharmD, Tom Wheelwright, CPA, Nina Klemm, and Patrick Lott
Learn more about your ad choices. Visit megaphone.fm/adchoices

SBA Financing for Pharmacies | Pharmacy Insiders

Drew Hegi and Bo Garmon
SBA Financing for Pharmacies
Why is FFB Qualified?
Is SBA the best option?
What types of loans are offered?
Can an existing loan be refinanced?
What information do you ask for?
What make a bankable loan?
How do you valuate a pharmacy?
What’s the difference between valuation and appraisal?
Learn more about your ad choices. Visit megaphone.fm/adchoices

Solidarity…The Only Way Forward – Nurses and LTC Pharmacies | Integra X-Files

Dr. Ernest Grant, president of the American Nurses Association, joins co-hosts Frances 
Nahas and Jim McDonald to discuss the role and circumstances of nursing at long-term care 
facilities – on-going staffing shortages, maintaining mental well-being, and how nurses’ deep 
commitment to caring for patients remains key. 
 
Listen in as they discuss ways LTC pharmacies and nursing can work together to improve 
communication and most importantly, patient care. 
Learn more about your ad choices. Visit megaphone.fm/adchoices

Linking Sex Therapy to Pharmacy with Lindsey Walden | Sex PharmD

I am a licensed professional counselor, and a certified sex therapist. I have spent the last 15 years in private practice helping couples and individuals with all types of relationship, communication, and sexual struggles.
Over the last few years I have started offering coaching and consulting services and transitioning to more of an online model but I do still have a small private practice that I will probably always keep going just because I love it.
I work with all elements of sexual functioning from arousal and desire struggles to orgasm problems to helping my clients maintain healthy sexual practices throughout their life cycle. 
In addition I focus a lot on individuals that identify as part of the LGBT community and make it a safe place for them to discuss things that may be on their mind.
I can be found all over social media, and the following link will give you access to everywhere you can find me https://www.lindsaywalden.com/connect-with-me
If you are needing to send me a direct email you can reach me lindsay@lindsaywalden.com or contact my office 314-485-9189.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacogenomics Changed My Life: A Patient’s Story, Kristen Ruth Davis | PGX For Pharmacists

Thanks for joining us today as our host, Dr. Jamie Wilkey talks with a patient, Kristen, who strongly feels that PGx testing saved her life. 
Join us for a patient’s side of the story today!
You may reach Kristen at her website: https://www.imnotcrazyproject.org/ her Facebook page: https://www.facebook.com/imnotcrazyproject or on LinkedIn: https://www.linkedin.com/in/kristen-ruth-davis-5540142a/
You may reach Jamie at her website: drjamiewilkey.com or on her LinkedIn page: https://www.linkedin.com/in/dr-jamie-wilkey/
*This episode discusses mental health and suicidal ideation. While it is not discussed in great detail, if you are having thoughts of ending your own life we strongly encourage you to push pause and call the National Suicide Prevention Hotline right away at 800-273-8255*
References:
IQVIA Institute for Human Data Science. Medicine Use and Spending in the U.S. https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-use-and-spending-in-the-us-a-review-of-2018-and-outlook-to-2023 Published May 2019. Accessed June 10, 2020.
Spear BB, Heath-Chiozzi M, Hu J. Clinical application of pharmacogenetics. Trends Mol. Med. 2001; 7, 201–204.
Table of Pharmacogenomic Biomarkers in Drug Labeling. U.S. Food and Drug Administration website.: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labelinghttps://www.fda.gov/Drugs/ScienceResearch/ucm572698.htm Accessed June 10, 2020.
Preventable Adverse Drug Reactions: A Focus on Drug Interactions. U.S. Food and Drug Administration website. www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm110632.htm. Accessed June 10, 2020.
Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014; 95(4):423‐431.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Defining Holistic, Integrative and Functional Medicine

Hi everyone, I’m super excited to be back with Season 5 of the Holistic Pharmacy Podcast!
And I have some announcements and updates to share with you about what I’ve been up to during the break between seasons.
I’ve partnered with the Pharmacy Podcast Network to expand my reach and to collaborate with like-minded professionals! And I will be changing the format of the podcast to include subject matter expert insights, journal clubs to dissect the latest literature together, and a regular FM segment in addition to bringing you inspiring stories that have always been at the heart of this show.
Joining me today and all season long are my co-hosts Dr. Lauren Castle and Dr. Jenna Carmichael. I interviewed Dr. Castle earlier in season 2, and Dr. Carmichael’s interview will be featured in the very next episode, so stay tuned for that!
We came together to share our perspectives on the various terms we commonly reference when in the realm of caring for our clients’ health. The slew of them can get quite confusing and overwhelming - holistic, natural, naturopathic, integrative, functional, complementary, alternative, not to mention conventional and allopathic! 
Join us as we break it down and set the stage for the rest of the season.
Related Episodes
S02E13 - Bridging Pharmacy and Functional Medicine with Dr. Lauren Castle - Dr. Marina Buksov
Hashtags: #holisticpharmacy, #holisticpharmacist, #herbalmedicine, #herbalism, #functionalmedicine, #integrative, #complementary, #alternative, #natural, #naturalmedicine, #naturopathic, #conventional, #allopathic, #traditional, #journalclub, #scientific, #spiritual, #holistic, #pharmacy, #pharmacist, #ppn, #collaboration, #cohost, #holisticpharmacypodcast
Learn more about your ad choices. Visit megaphone.fm/adchoices

PQA Social Determinants of Health Resource Guide Review

The PQA Social Determinants of Health (SDOH) Resource Guide profiles 20 real-world SDOH services that are promising for improving the quality and safety of medication use. Created by the Pharmacy Quality Alliance (PQA), the guide focuses on SDOH screenings, referrals and interventions conducted by or involving pharmacists or pharmacies. The guide covers services that address seven SDOH barriers, and many of the initiatives profiled address multiple barriers:
Cost of Medications  
Cultural or Literacy Barriers  
Decent, Safe and Affordable Housing  
Food Security  
Screening for Unmet Needs  
Social Isolation  
Transportation 
This is the first resource guide that catalogues pharmacist and pharmacy-centered SDOH services. The guide provides health care professionals with ideas and examples of SDOH services they can implement and was designed to be widely used in many different settings. The guide provides information on each service’s location, scale, target population, care setting, intervention and outcomes. 
LINK HERE: https://pharmacypodcast.com/2022/02/25/pqa-social-determinants/
PQA welcomes feedback on the guide and suggestions on SDOH services which can be highlighted in future editions. You can submit feedback and interventions for consideration below. 
This activity was supported by an independent medical education grant from Merck & Co. and by Humana, whose mission is to help people achieve lifelong wellbeing.  
Learn more about your ad choices. Visit megaphone.fm/adchoices

Medications for Opioid Use Disorder | Let’s Talk Stigma

In this episode of Let’s Talk Stigma, we will hear about medications for opioid use disorder, or “MOUD,” and how patient accessibility to these medications can play a huge role in helping someone reach recovery.
The Pennsylvania Pharmacists Association has partnered with Pharmacy Podcast Network to bring you a series of podcasts designed to help community pharmacists implement change and practice transformation. The Let’s Talk Stigma podcast miniseries is designed to equip community-based pharmacists to provide culturally sensitive care to individuals with opioid use disorders.
This podcast miniseries was developed by the University of Pittsburgh School of Pharmacy in collaboration with Duquesne University School of Pharmacy and paid for through CDC grant funding provided by the Allegheny County Health Department to the University of Pittsburgh and Duquesne University Schools of Pharmacy.
Did you listen to all 5 podcasts? Visit the link below to complete the post test and evaluation. 1.5 hours of CE credit is available only for Pharmacists and Pharmacy Technicians. Once you click on the link below, you will need to click register on the left-hand side of your screen, complete the registration fields, and you will be sent an e-mail with information on how to access the post test and evaluation. 
 
Link: https://www.lecturepanda.com/a/LetsTalkStigma1
CE Information
Target Audience: Pharmacists and Pharmacy Technicians
CE Credit: 1.5 Contact Hours (0.15 CEU)
UAN: 0159-9999-22-011-H08-P; 0159-9999-22-011-H08-T
Activity Type: Knowledge
 
If you have any questions about LecturePanda or receiving credit for this course, please use the help desk feature located within LecturePanda. You can also contact PPA at ppa@papharmacists.com
The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Did you listen to all 5 podcasts? Visit the link below to complete the post test and evaluation. 1.5 hours of CE credit is available only for Pharmacists and Pharmacy Technicians. Once you click on the link below, you will need to click register on the left-hand side of your screen, complete the registration fields, and you will be sent an e-mail with information on how to access the post test and evaluation. 
 
Link: https://www.lecturepanda.com/a/LetsTalkStigma1
CE Information
Target Audience: Pharmacists and Pharmacy Technicians
CE Credit: 1.5 Contact Hours (0.15 CEU)
UAN: 0159-9999-22-011-H08-P; 0159-9999-22-011-H08-T
Activity Type: Knowledge
 
If you have any questions about LecturePanda or receiving credit for this course, please use the help desk feature located within LecturePanda. You can also contact PPA at ppa@papharmacists.com
  
The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Kelsey Hennig | Occuptation Station

Kelsey Hennig '18 is the perfect example of the power of mentorship. In this episode of Occupation Station, Henning talks about the incredible guidance she received while at ACPHS and how she now tries to give that back as a clinical assistant professor at Binghamton University. Henning says it was some of that mentorship during a research opportunity at ACPHS that helped her realize her passion for the study of the patient/provider relationship.
Hennig was so impressed with the education that she received at ACPHS that she later returned as a PGY2 resident to learn more about the transitions of care field. From her experiences both as a student and now as a teacher, Hennig has a clear view of what is required for a successful learning environment. One of her greatest goals is to try to remove any sense of shame that some students have as they try to master new material. Hennig knows that to get a full understanding of any field of study a student has to be confident that making mistakes is a part of the learning process. She also shares advice with students about staying open-minded about their ultimate career goals. Hennig says earning a degree at ACPHS can take a student in unlimited and incredible directions.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Naloxone and Harm Reduction Services | Let’s Talk Stigma

In this episode of Let’s Talk Stigma, we will hear about the impact that both naloxone and harm reduction services have on the lives of individuals with opioid use disorder. We will hear from patients, practitioners, family members and those who work directly with people who use drugs.
The Pennsylvania Pharmacists Association has partnered with Pharmacy Podcast Network to bring you a series of podcasts designed to help community pharmacists implement change and practice transformation. The Let’s Talk Stigma podcast miniseries is designed to equip community-based pharmacists to provide culturally sensitive care to individuals with opioid use disorders.
This podcast miniseries was developed by the University of Pittsburgh School of Pharmacy in collaboration with Duquesne University School of Pharmacy and paid for through CDC grant funding provided by the Allegheny County Health Department to the University of Pittsburgh and Duquesne University Schools of Pharmacy.
Learn more about your ad choices. Visit megaphone.fm/adchoices